Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Coeptis Therapeutics Holdings (COEPW) Depreciation & Amortization (IS) (2023 - 2025)

Coeptis Therapeutics Holdings has reported Depreciation & Amortization (IS) over the past 3 years, most recently at $250000.0 for Q2 2025.

  • Quarterly results put Depreciation & Amortization (IS) at $250000.0 for Q2 2025, changed 0.0% from a year ago — trailing twelve months through Jun 2025 was $1.0 million (changed 0.0% YoY), and the annual figure for FY2024 was $1.0 million, changed 0.0%.
  • Depreciation & Amortization (IS) for Q2 2025 was $250000.0 at Coeptis Therapeutics Holdings, roughly flat from $250000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (IS) for COEPW hit a ceiling of $250000.0 in Q1 2023 and a floor of $250000.0 in Q1 2023.
  • Median Depreciation & Amortization (IS) over the past 3 years was $250000.0 (2023), compared with a mean of $250000.0.
  • Peak annual rise in Depreciation & Amortization (IS) hit 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
  • Coeptis Therapeutics Holdings' Depreciation & Amortization (IS) stood at $250000.0 in 2023, then changed by 0.0% to $250000.0 in 2024, then changed by 0.0% to $250000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (IS) were $250000.0 (Q2 2025), $250000.0 (Q1 2025), and $250000.0 (Q4 2024) per Business Quant data.